Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Venous Thrombosis × Dalteparin × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 10 Gastrointestinal 2 Thoracic 1 CNS 1

Conditions

Lung Neoplasms 4 Thromboembolism 2 Carcinoma, Non-Small-Cell Lung 2 Venous Thrombosis 1 Venous Thromboembolism 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pulmonary Embolism 1 Prostatic Neoplasms 1 Hemorrhage 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Tinzaparin 1 Nadroparin 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334007 2018-09-18

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

McMaster University

Phase 1/2 Completed

Classical hematologyThoracic

Lung Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡